Regårdh C G, Landahl S, Larsson M, Lundborg P, Steen B, Hoffmann K J, Lagerström P O
Eur J Clin Pharmacol. 1983;24(2):221-6. doi: 10.1007/BF00613821.
The absorption and disposition of metoprolol have been evaluated in 10 healthy, non-smoking, elderly individuals (mean age 73.1 years) by simultaneous determination of [3H]-metoprolol and unlabelled metoprolol. The labelled drug was given as an intravenous tracer dose, immediately followed by oral metoprolol 25 mg. The experiment was preceded by administration of metoprolol 25 mg b.i.d. for 3 days. The volume of distribution, elimination half-life and total body clearance were almost the same as previously observed in healthy, young subjects. The mean systemic availability was about 39% in the elderly, which is lower than the mean of 55% observed in a control group of young volunteers who received 50 mg b.i.d. In the elderly, the mean plasma concentration of alpha-OH-metoprolol was about twice as high as that of the parent drug, whereas the opposite was true of the control group. The results indicate that age-related physiological changes have a negligible effect on the pharmacokinetics of metoprolol.
通过同时测定[³H]-美托洛尔和未标记的美托洛尔,在10名健康、不吸烟的老年人(平均年龄73.1岁)中评估了美托洛尔的吸收和处置情况。标记药物以静脉示踪剂量给药,随后立即口服25mg美托洛尔。实验前连续3天每天两次给予25mg美托洛尔。分布容积、消除半衰期和全身清除率与之前在健康年轻受试者中观察到的几乎相同。老年人的平均系统利用率约为39%,低于接受50mg每日两次的年轻志愿者对照组中观察到的55%的平均值。在老年人中,α-羟基美托洛尔的平均血浆浓度约为母体药物的两倍,而对照组情况相反。结果表明,与年龄相关的生理变化对美托洛尔的药代动力学影响可忽略不计。